dievini Hopp BioTech holding GmbH & Co. KG
Venture capital1 people tracked
Investment thesis
dievini backs life and health sciences companies developing innovative therapeutic and diagnostic approaches with the potential to enable entirely new treatment forms, aiming to give doctors and patients more effective and better-tolerated therapies in mostly life-threatening indications. Its portfolio companies pursue novel, often first-in-class approaches. Indication focus areas include oncology, neurology, infectious diseases, cell therapy, and improved drug formulation. In molecular diagnostics, the emphasis is on systems and products for personalized medicine that improve individual therapeutic success while reducing side effects. Geographically, dievini focuses on Germany and Europe while supporting portfolio companies in their global development and commercialization.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's websiteFrequently asked questions
- What sectors does dievini Hopp BioTech holding GmbH & Co. KG focus on?
- dievini Hopp BioTech holding GmbH & Co. KG focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
Similar investors
GV, originally launched as Google Ventures in 2009, is an independent venture capital firm with Alphabet as its sole limited partner. It invests from seed to growth stages across technology and life sciences and supports founders with operating partners and access to Google and Alphabet resources.
Overwater Ventures is an early-stage investor backing companies redefining everyday experiences, investing at pre-seed and seed stages.
Everywhere Ventures is a global pre-seed venture capital firm founded in 2018 and headquartered in New York, investing $250,000 into early-stage technology companies. It runs a community-led model backed by 500+ founder and operator LPs.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Patient Square Capital is a health care-focused investment firm that partners with management teams building products, services, and technologies that improve health, investing across the health care sector's subsectors.